NDC 72572-553-01 - Pantoprazole Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72572-553
- Requested NDC
- 72572-553-01
- Package NDCs from labels
- 72572-553-01, 72572-553-10
- Manufacturer
- Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A.
- Effective date
- 2026-10-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Pantoprazole Sodium - Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | 2026-10-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72572-553-01 | Pantoprazole Sodium | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | 1 | |
| 72572-553-10 | Pantoprazole Sodium | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72572-553-01 | EA - Each | 72572-553 | 0bbedf50-986c-4360-83dc-17bef5fe1e9f | 1 | 2025-08-11 |
| 72572-553-10 | EA - Each | 72572-553 | 7323e586-26c9-497c-98e4-83930a2f1185 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Protonix I.V. | PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 51e4144a-489e-436c-609a-39305f8f56ba | 2025-12-22 | Warnings, Adverse reactions | 283669 6871619Q5X |
| Protonix I.V. | PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | f39b3e7d-39d2-4c8a-9974-4ab885241880 | 2025-12-22 | Warnings, Adverse reactions | 283669 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | QPharma Inc | b4a94a37-47c1-4dd9-9e4d-5b4a03480aa6 | 2025-12-04 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | AvPAK | b9fa8381-b75e-b1cd-e053-2a95a90a9883 | 2025-12-03 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | QPharma Inc | fbd035d0-529c-6033-e053-6294a90abf07 | 2025-12-02 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium | PANTOPRAZOLE SODIUM | Ajanta Pharma USA Inc. | 90963a38-f629-45a4-bddd-9e13a55fe0f7 | 2025-11-26 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE | PHOENIX RX LLC | 440b9ae8-2fb8-5d35-e063-6294a90a82b6 | 2025-11-20 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | PHOENIX RX LLC | 43fc6326-cfe6-7d1c-e063-6394a90abc24 | 2025-11-19 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | Advanced Rx of Tennessee, LLC | 4136d983-75fa-9604-e063-6294a90aaac6 | 2025-10-15 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM I.V. | PANTOPRAZOLE SODIUM | Piramal Critical Care | 0696b10c-972b-9dcf-e063-6294a90a1034 | 2025-10-07 | Warnings, Adverse reactions | 283669 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE | Bryant Ranch Prepack | d212e8ec-f7ff-4727-a83e-0edc4ca7e6d1 | 2025-09-26 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole sodium delayed-release | PANTOPRAZOLE SODIUM DELAYED-RELEASE | Lifestar Pharma LLC | 0502f935-af7a-4f1e-8c3e-29e20647c885 | 2025-09-08 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM I.V. | PANTOPRAZOLE SODIUM | Sandoz Inc | 22b71a1d-87f8-43ba-b53d-53ca3f70c63e | 2025-07-30 | Warnings, Adverse reactions | 283669 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Devatis Inc. | 13c337e7-1e7b-47bd-9f88-92b0d548ca9c | 2025-07-30 | Warnings, Adverse reactions | 283669 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Mylan Institutional Inc. | a9b0d279-118b-4372-bd51-d4bad9c1cfca | 2025-07-22 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Meitheal Pharmaceuticals Inc. | 014f9762-6948-46b7-8659-5c89f35ad8bf | 2025-06-27 | Warnings, Adverse reactions | 283669 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Aphena Pharma Solutions - Tennessee, LLC | c9bc288b-e84c-4e31-a769-c87a59226086 | 2025-06-09 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM INJECTION | Alembic Pharmaceuticals Limited | 02ee7ed6-217f-4128-bbbb-b9390475a65b | 2025-04-07 | Warnings, Adverse reactions | 283669 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM INJECTION | Alembic Pharmaceuticals Inc. | a9e5fac6-2db6-4311-a98b-eb3f0dde19d6 | 2025-04-07 | Warnings, Adverse reactions | 283669 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Rising Pharma Holdings, Inc. | 91a6b13f-457f-4136-9541-c4adb9c3c35c | 2025-04-02 | Warnings, Adverse reactions | 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.